Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast Cancer
Esther Sanfeliu(Hospital Clínic de Barcelona), Aleix Prat(Hospital Clínic de Barcelona), Juan Miguel Cejalvo(Universitat de València), Sandra Cobo(Breast Cancer Research Foundation), Marta Tapia(Hospital Clínico Universitario de Valencia), Blanca González‐Farré(Hospital Clínic de Barcelona), Rodrigo Sánchez-Bayona(Research Institute Hospital 12 de Octubre), Jesús Soberino(Hospital Quirónsalud Barcelona), Anabel Martínez-Romero(Josep Carreras Leukaemia Research Institute), Francisco J. Pardo-Palacios(Breast Cancer Research Foundation), Eva Hernández‐Illán(Hospital Clínic de Barcelona), Javier Cortés(Villa Maria Hospital), Joel S. Parker(University of North Carolina at Chapel Hill), Olga Martínez‐Sáez(Breast Cancer Research Foundation), Cristina Tebar(Hospital Clínico Universitario de Valencia), Laia Paré(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Kepa Amillano(Hospital Universitari Sant Joan de Reus), Santiago Escrivá-de-Romaní(Unknown), Eva Ciruelos(Hospital Universitario 12 De Octubre), Patricia Villagrasa, Cristina Saura(Vall d'Hebron Hospital Universitari), Wesley Buckingham(Hospital Costa del Sol), Mercedes Marín‐Aguilera(Oryzon Genomics (Spain)), Serafín Morales(Hospital Universitari Arnau de Vilanova), Montserrat Muñoz-Mateu(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Pedro Jares(Hospital Clínic de Barcelona), Joan Anton Puig‐Butillé(Hospital Clínic de Barcelona), Fara Brasó‐Maristany(Hospital Clínic de Barcelona)
Cited by 3
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k